Recurrent laryngeal nerve thermal injury in radiofrequency ablation for papillary thyroid carcinoma and related risk factors: a prospective large cohort study
- PMID: 40050454
- DOI: 10.1007/s00330-025-11448-w
Recurrent laryngeal nerve thermal injury in radiofrequency ablation for papillary thyroid carcinoma and related risk factors: a prospective large cohort study
Abstract
Objective: To establish a prediction model for recurrent laryngeal nerve thermal injury (RLNTI) in radiofrequency ablation (RFA) of papillary thyroid carcinoma (PTC).
Materials and methods: This prospective study was conducted at a single center from July 2016 to September 2022. Patients diagnosed with PTC and received US-RFA by different interventional therapy groups were enrolled, and classified as derivation cohort and validation cohort based on therapy groups. The logistic regression analysis was used in derivation cohort to develop the model and internal and external validation was performed in derivation and validation cohort respectively.
Results: The derivation cohort included 1632 patients (mean age, 40 years, ±11 (standard deviation), 1300 female), and the validation cohort comprised 755 patients (mean age, 38 years, ±11 (standard deviation), 584 female). Three variables were independently associated with RLNTI: the minimum distance from tumor to tracheoesophageal groove (TEG-D) ≤ 2.95 mm (odds ratio, 8.179; p < 0.0001), tumor posterior location (odds ratio, 3.849; p = 0.0008) and ablation energy > 0.695 kcal (odds ratio, 4.537; p < 0.0001). The area under the receiver operating characteristic curve (AUC) of the model in the derivation cohort, validation cohort, and total group were 0.877 (95% CI: 0.845, 0.910), 0.901 (95% CI: 0.835, 0.967) and 0.886 (95% CI: 0.85, 0.915) respectively. The calibration plot and Hosmer-Lemeshow test demonstrated a good fit (χ² = 3.49, p = 0.321).
Conclusion: The prediction model of RLNTI was derived based on TEG-D, tumor posterior location, and ablation energy and exhibited good discrimination and calibration abilities.
Key points: Question Recurrent laryngeal nerve thermal injury (RLNTI) is a major complication of radiofrequency ablation (RFA) for papillary thyroid carcinoma (PTC), while related risk factors are unclear. Findings The minimum distance from tumor to tracheoesophageal groove ≤ 2.95 mm, tumor posterior location, and ablation energy > 0.695 kcal are factors independently associated with RLNTI. Clinical relevance This study developed a simple prediction model with good discrimination and calibration abilities, which provided interventional radiologists an evidence-based method to predict RLNTI and thereby reduce the incidence of RLNTI in RFA of PTC.
Keywords: Papillary thyroid carcinoma; Radiofrequency ablation; Recurrent laryngeal nerve thermal injury; Ultrasound.
© 2025. The Author(s), under exclusive licence to European Society of Radiology.
Conflict of interest statement
Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is JianQiao Zhou. Conflict of interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: One of the authors, statistician YanYan Song has significant statistical expertise. Informed consent: Written informed consent was obtained from all patients in this study. Ethical approval: Institutional Review Board approval was obtained. Study subjects or cohorts overlap: The study subjects or cohorts have not been previously reported. Methodology: Prospective Observational study Performed at one institution
References
-
- Baek JH, Cho SJ (2021) Thermal ablation for small papillary thyroid cancer: a potential game changer. Radiology 300:217–218 - PubMed
-
- Muhammad H, Santhanam P, Russell JO (2021) Radiofrequency ablation and thyroid nodules: updated systematic review. Endocrine 72:619–632 - PubMed
-
- Li X, Yan L, Xiao J et al (2024) Long-term outcomes and risk factors of radiofrequency ablation for T1N0M0 papillary thyroid carcinoma. JAMA Surg 159:51–58 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
